<DOC>
	<DOCNO>NCT01155609</DOCNO>
	<brief_summary>This pilot clinical trial study L-lysine treat oral mucositis patient undergo radiation therapy without chemotherapy head neck cancer . L-lysine may lessen severity oral mucositis , mouth sore patient receive radiation therapy without chemotherapy head neck cancer</brief_summary>
	<brief_title>L-lysine Treating Oral Mucositis Patients Undergoing Radiation Therapy With Without Chemotherapy For Head Neck Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine complete response rate , decrease severity , time complete response oral mucositis relate head neck cancer irradiation chemotherapy use L-lysine supplementation daily . SECONDARY OBJECTIVES : I . To determine functional impact use L-lysine oral mucositis daily life measure Functional Life Index-Cancer ( FLIC ) Questionnaire total score . OUTLINE : Patients receive L-lysine orally ( PO ) daily ( QD ) completion radiotherapy resolution mucositis absence disease progression unacceptable toxicity . After completion study treatment , patient follow weekly mucositis resolve .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Laryngeal Diseases</mesh_term>
	<mesh_term>Laryngeal Neoplasms</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Verrucous</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Salivary Gland Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Adenoid Cystic</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Carcinoma , Mucoepidermoid</mesh_term>
	<criteria>Cytologically pathologically proven cancer oropharynx , lip , oral cavity , larynx , hypopharynx , nasopharynx , salivary gland Predicted life expectancy great 12 week Eastern Cooperative Oncology Group ( ECOG ) Performance Status 02 Renal function calculate creatinine clearance 55 ml/min great , per CockcroftGault formula Patients undergoing radiation therapy without concurrent chemotherapy Ability understand willingness sign write informed consent document Exclusion Criteria Use illicit drug , alcohol abuse , tobacco abuse treatment Subjects may receive investigational agent Inability unwillingness comply radiation therapy chemotherapy regimens Inability unwillingness take daily LLysine supplementation prescribe Use arginine supplementation History renal failure compromise</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>